For the first time India and WHO face off, HCQ has no side effects: ICMR

New delhi date. 27 May 2020, Wednesday

For the first time, India has rejected the recommendations of the World Health Organization in treating the corona virus epidemic. Despite worldwide debate over the WHO's negligence in spreading the corona virus, India has remained silent on the issue. But the country's scientists have rejected the WHO's new recommendations in the treatment of corona virus.

The WHO has expressed doubts about the use of the drug hydroxychloroquine in the treatment of corona virus. It is said that this drug is not safe for the treatment of corona virus. The Indian Council of Medical Research (ICMR) said that a study conducted in India did not find any side effects of the malaria drug Hydroxychloroquine (HCQ) and that its use could be continued in the treatment of Covid-19 under intensive medical supervision.

An official from the Union Ministry of Health says that in the last five months, the WHO's guidelines have been proven wrong in many respects. For this reason, India has now decided to seek its own treatment instead of acting on the advice or direction of any other organization. The Indian government now wants to rely on its own research and discovery to fight the corona virus. Currently, the ministry refuses to accept the WHO's recommendation only for hydroxycloquine. But in the future, there may be differences with the WHO on a number of issues.

Indian Council of Medical Research (ICMR) Director General Balram Bhargava said, "Kovid-19 is a disease about which information is slowly coming to light and we do not know which medicine is working and which is not. Remained. How many drugs are being prescribed for Covid-19, whether it be for prevention or for treatment? '

The US has identified hydroxychloroquine, a malaria drug manufactured in India, as the most effective against the corona virus. Recently, the President of the United States also said that many Americans have completely recovered from this drug.